Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajendra Uprety

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|August 6, 2014
Multifunctionalization of cetuximab with bioorthogonal chemistries and parallel EGFR profiling of cell-lines using imaging, FACS and immunoprecipitation approachesMelanie L Reschke, Rajendra Uprety, Imithri Bodhinayake, et al.
Journal of the American Chemical Society|March 4, 2015
Conditional control of alternative splicing through light-triggered splice-switching oligonucleotidesJames Hemphill, Qingyang Liu, Rajendra Uprety, et al.
Journal of the American Chemical Society|October 24, 2014
Genetically encoded optochemical probes for simultaneous fluorescence reporting and light activation of protein function with two-photon excitationJi Luo, Rajendra Uprety, Yuta Naro, et al.
Cellular and Molecular Neurobiology|May 20, 2020
Synthesis and Characterization of Azido Aryl Analogs of IBNtxA for Radio-Photoaffinity Labeling Opioid Receptors in Cell Lines and in Mouse BrainSteven G Grinnell, Rajendra Uprety, Andras Varadi, et al.
Neuropharmacology|December 31, 2020
The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic painDiana Vivian Atigari, Kelly Frances Paton, Rajendra Uprety, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 CoreAllison Zarkin, Rajwana Jahan, Rajendra Uprety, et al.
Cellular and Molecular Neurobiology|January 12, 2021
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid WithdrawalLisa L Wilson, Soumen Chakraborty, Shainnel O Eans, et al.
British Journal of Pharmacology|November 10, 2019
G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorderAnna M Gutridge, Meridith T Robins, Robert J Cassell, et al.
Neuropharmacology|August 16, 2017
Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplaceMichael H Baumann, Susruta Majumdar, Valerie Le Rouzic, et al.
European Journal of Medicinal Chemistry|January 1, 2019
Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (σ<sub>1</sub>) receptor selective ligandsRajendra Uprety, András Váradi, Abdullah Allaoa, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|August 6, 2014
Multifunctionalization of cetuximab with bioorthogonal chemistries and parallel EGFR profiling of cell-lines using imaging, FACS and immunoprecipitation approachesMelanie L Reschke, Rajendra Uprety, Imithri Bodhinayake, et al.
Journal of the American Chemical Society|March 4, 2015
Conditional control of alternative splicing through light-triggered splice-switching oligonucleotidesJames Hemphill, Qingyang Liu, Rajendra Uprety, et al.
Journal of the American Chemical Society|October 24, 2014
Genetically encoded optochemical probes for simultaneous fluorescence reporting and light activation of protein function with two-photon excitationJi Luo, Rajendra Uprety, Yuta Naro, et al.
Cellular and Molecular Neurobiology|May 20, 2020
Synthesis and Characterization of Azido Aryl Analogs of IBNtxA for Radio-Photoaffinity Labeling Opioid Receptors in Cell Lines and in Mouse BrainSteven G Grinnell, Rajendra Uprety, Andras Varadi, et al.
Neuropharmacology|December 31, 2020
The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic painDiana Vivian Atigari, Kelly Frances Paton, Rajendra Uprety, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 CoreAllison Zarkin, Rajwana Jahan, Rajendra Uprety, et al.
Cellular and Molecular Neurobiology|January 12, 2021
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid WithdrawalLisa L Wilson, Soumen Chakraborty, Shainnel O Eans, et al.
British Journal of Pharmacology|November 10, 2019
G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorderAnna M Gutridge, Meridith T Robins, Robert J Cassell, et al.
Neuropharmacology|August 16, 2017
Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplaceMichael H Baumann, Susruta Majumdar, Valerie Le Rouzic, et al.
European Journal of Medicinal Chemistry|January 1, 2019
Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (σ<sub>1</sub>) receptor selective ligandsRajendra Uprety, András Váradi, Abdullah Allaoa, et al.
Pageof 3